EVENT PREVIEW
“UBM Live was one of the first event organisers to be awarded BS 8901 certification, the British Standard that specifies sustainable businesses in the events industry and which includes concern for environmental, economic and social issues,” he says. “The event in Madrid offers a unique opportunity to raise awareness among attendees, exhibitors and the local community about the benefits of sustainable living, and enhances environmental best practice in the region. UBM Live is encouraging attendees and exhibitors to make sustainability a real priority by travelling by train or carbon- offsetting flights, using public transport while attending the events, and staying in hotels near the Feria de Madrid. We are also asking exhibitors to find ways to minimise waste production by using disposable products during the events, and recycling and re-using exhibition and booth construction materials. And a final important point is that we encourage exhibitors, attendees and members of the press to minimise the amount of paper they may accumulate.
High-standard exhibits With such a large number of exhibiting companies at the events only a brief sketch can be made of what types of product and service offerings will be available but the following gives an indication of the high quality of exhibits at these not-to-be-missed events:
Evonik (Stand 4A32) is a leading manufacturer and supplier of speciality chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy and the company benefits specifically from its expertise in innovation and its integrated technology platforms. Evonik is active in more than 100 countries and with more than 33,000 employees in fiscal 2011 generated sales of about €14.5 billion and an operating profit (adjusted EBITDA) of about €2.8 billion.
Almac (Stand 10E41) is a privately owned organisation with more than 30 years’ experience offering services in R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS® technology (IVRS/IWRS), and commercial-scale manufacture. Almac provides services to more than 600 companies, including international leaders in the pharmaceutical and biotech sectors. The company employs more than 3,000 people and is headquartered in Craigavon, UK. Its US operations are based in Pennsylvania, North Carolina and California.
abcr (Stand 8C52) is an established supplier of speciality chemicals, including organo- silanes, speciality fluorinated organics, inorganics, catalysts, metallo-organics, and heterocycles. abcr supplies globally more than 60,000 items and is focused on the individual needs of pharmaceutical, agrochemical and material science orientated companies. Support from its chemists and worldwide sourcing activities, combined with reliable delivery of chemicals in excellent quality at competitive prices have made abcr the ‘preferred supplier’ of many customers from catalogue to bulk quantities. The company’s new production facility, abcr labs, started operations at the beginning of 2010 and provides contract services for custom synthesis, product and process development, scale-up and commercialisation.
American Peptide Company, Inc (APC) (Stand 4F46NA) offers comprehensive selections of pre-manufactured catalogue peptides, custom synthesis, and GMP peptide active pharmaceutical ingredients. The company’s California-based manufacturing facilities offer synthesis services under non-GMP (Sunnyvale, California) and cGMP (Vista, California) conditions. cGMP manufacturing is performed under strict adherence to FDA Regulations 21 CFR parts 210, 211 and ICH Guidance Q7A. The company’s Total Peptide Management services support clients in the drug development process from the preclinical to the commercial stage. Value-added services include process development, scale-up production, analytical/process validation, stability studies, CMC, DMF, and regulatory support.
Cambrex Corporation (Stand 9H28) is a leading supplier of products and services to the life sciences industry. The company has built a comprehensive platform of chemical technologies for the synthesis of small- molecule APIs and for drug delivery. Cambrex has extensive experience developing drug substances from early-stage to commercial supply, from grams to tons. The company’s broad range of services include route selection, process & analytical development, process scale-up, safety assessments, optimisation and formulation, and an extensive list of generic APIs. Cambrex’s offerings include controlled substances, high-potency products/cytotoxics, high-energy compounds, polymeric drug delivery, biocatalysis/biotransformations, chiral synthesis, hydrogenation and nitration.
Lonza Custom Manufacturing (Stand 9H10) has been helping pharmaceutical and biotech companies of all sizes improve and advance their products for more than 30 years. APIs, HAPIs, conjugates, peptides, vaccines, plasmid DNA, recombinant proteins, Fabs, mAbs, and cell therapy are among the many services Lonza provides. The company has the know-how and track record to handle almost any pharmaceutical or biotechnology challenge. From preclinical to commercial supply, Lonza’s complete development services, manufacturing processes and broad technology platform enable customers’ products to reach their full potential.
Peptisyntha (Stand 3D70), located in Belgium and the USA, is a leading manufacturer of therapeutic peptide APIs and peptidomimetics. With more than 20 years of
September/October 2012 sp2 Inter-Active 41
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44